TNFRSF1A and type 2 diabetes mellitus: A report has also been published indicating that the Janus kinase inhibitor baricitinib lowers TNFR levels in patients with type 2 diabetes, while another report suggested that the renin-angiotensin-system inhibitor losartan does not have the same effect26.